News
AACI Announces New CRI Steering Committee Members
Pictured, clockwise from top left: Drs. Edward J. Kim, Stephanie Brogan, Wencesley A. Paez, and Kelli Thorne
The AACI Clinical Research Innovation (CRI) Steering Committee is pleased to announce the appointment of Edward J. Kim, MD, PhD, as its new chair-elect, effective October 1, 2026. Dr. Kim serves as interim chief for the Division of Hematology and Oncology and professor of medicine at UC Davis Comprehensive Cancer Center. He will serve one year as chair-elect before assuming the role of CRI chair in October 2027, succeeding Margie Kasner, MD, MSCE.
CRI is also pleased to welcome three newly elected steering committee members:
- Stephanie Brogan, CCRP, senior director of the clinical trials office, Dana-Farber Cancer Institute, Harvard Medical School
- Wencesley A. Paez, MD, MS, director of clinical research operations, Fox Chase Cancer Center, Temple University
- Kelli Thorne, MPH, CCRP, director of the research compliance office, Huntsman Cancer Institute, University of Utah
The committee extends its sincere appreciation to members who are completing their terms:
- Muhammad Furqan, MBBS, Holden Comprehensive Cancer Center
- Dina Aziz, MSHS, The University of Texas MD Anderson Cancer Center
- Angela Campbell, MS, The Ohio State University Comprehensive Cancer Center – The James